4//SEC Filing
Rothblum Maydan 4
Accession 0001493152-24-008813
CIK 0001854445other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 10:11 AM ET
Size
9.6 KB
Accession
0001493152-24-008813
Insider Transaction Report
Form 4
Rothblum Maydan
DirectorChief Financial Officer & COO
Transactions
- Disposition to Issuer
Stock Option (Right to Purchase)
2024-02-29−320,180→ 0 total→ Common Stock (320,180 underlying) - Award
Stock Option (Right to Purchase)
2024-03-01+306,145→ 306,145 totalExp: 2031-03-01→ Common Stock (306,145 underlying)
Footnotes (3)
- [F1]Represents the forfeiture of fully vested options to purchase an aggregate of 320,180 shares of common stock granted under the issuer's 2016 equity incentive plan, as amended (the "2016 Plan"), consisting of options to purchase (i) 25,008 shares of common stock and 8,328 shares of common stock granted on September 1, 2019 and September 1, 2020, respectively, with an exercise price of $4.00/share, (ii) 33,333 shares of common stock granted on January 1, 2021 with an exercise price of $4.50/share, (iii) 8 shares of common stock and 3 shares of common stock granted on September 1, 2020 and January 1, 2021, respectively, with exercise prices of $4.00/share and $4.50 /share, respectively, (iv) 2,333 shares of common stock and 1,167 shares of common stock granted on July 1, 2020 and August 1, 2020, with an exercise price of $4.50/share, and (v) 250,000 shares of common stock granted on June 20, 2017, with an exercise price of $2.50.
- [F2]The options in footnote (1) were to expire 10 years from their respective grant dates.
- [F3]Mr. Rothblum was granted options to purchase an aggregate of 306,145 shares of the issuer's common stock under the 2016 Plan on March 1, 2023, consisting of (i) options to purchase 18,715 shares of common stock, at an exercise price of $3.00 per share, which options vest on March 1, 2025, (ii) options to purchase 18,715 shares of common stock, at an exercise price of $2.50 per share, which options vest on March 1, 2026, (iii) options to purchase 18,715 shares of common stock, at an exercise price of $2.00 per share, which options vest on March 1, 2027, and (iv) options to purchase 250,000 shares of common stock, at an exercise price of $1.50 per share, which vest monthly over 45 months. All of the foregoing options, other than the option to purchase 250,000 shares of common stock, expire seven years from the grant date. The option to purchase 250,000 shares of common stock expires ten years from the grant date.
Documents
Issuer
Glimpse Group, Inc.
CIK 0001854445
Entity typeother
Related Parties
1- filerCIK 0001526161
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 10:11 AM ET
- Size
- 9.6 KB